HIGH

Glenmark Pharmaceuticals Recalls Carvedilol Tablets Over Nitrosamine Contamination

Glenmark Pharmaceuticals recalled 44,328 bottles of Carvedilol Tablets, USP, 3.125 mg on August 7, 2025. The recall follows the discovery of N-Nitroso Carvedilol I impurity above acceptable levels. Consumers should stop using this medication immediately and consult their healthcare providers.

Quick Facts at a Glance

Recall Date
August 7, 2025
Hazard Level
HIGH
Brands
Glenmark Pharmaceuticals, CARVEDILOL
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

CGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Product Details

The recall includes Carvedilol Tablets in 500-count bottles (NDC 68462-162-05) and 100-count bottles (NDC 68462-162-01). These products were distributed nationwide in the USA and manufactured by Glenmark Pharmaceuticals Ltd in Goa, India.

The Hazard

The recall was issued due to CGMP deviations resulting in the presence of N-Nitroso Carvedilol I, a nitrosamine impurity. This impurity is above the current acceptable intake level, which poses potential health risks to consumers.

Reported Incidents

No specific injuries or incidents have been reported related to this recall. The FDA classified this recall as Class II, indicating a potential health hazard.

What to Do

Consumers and healthcare providers should stop using the affected Carvedilol Tablets immediately. Contact Glenmark Pharmaceuticals Inc. or your healthcare provider for further guidance and to discuss possible alternatives.

Contact Information

For more information, consumers can call Glenmark Pharmaceuticals Inc. or visit their official website. The recall notification has also been sent via letter.

Key Facts

  • Recall date: August 7, 2025
  • Total quantity recalled: 44,328 bottles
  • Affected product: Carvedilol Tablets, USP, 3.125 mg
  • Hazard: Nitrosamine contamination above acceptable levels

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
NDC 68462-162-05
NDC 68462-162-01
Lot#: a)19242274
19242275
19242272
+3 more
UPC Codes
68462-162
68462-163
68462-164
+11 more
Affected States
ALL
Report Date
August 20, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more